Published in Gene Therapy Weekly, September 18th, 1995
Aruna Nathan, Harvard-Massachusetts Institute of Technology, Cambridge, Massachusetts, and colleagues reported what they believe is the first report describing extravascular cell implants as controlling vasculoproliferative disease ("Tissue Engineered Perivascular Endothelial Cell Implants Regulate Vascular Injury," Proceedings of the National Academy of Science, August 1995;92:8130-8134).
"Tissue engineered cells offer the potential for potent methods of vascular growth regulation and insight into the complex autocrine-paracrine control...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.